XERIS BIOPHARMA HOLDINGS INC's ticker is and the CUSIP is 98422E103. A total of 104 filers reported holding XERIS BIOPHARMA HOLDINGS INC in Q3 2022. The put-call ratio across all filers is 0.16 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,002,592 | -23.6% | 5,915,372 | +7.5% | 3.66% | -29.7% |
| Q2 2023 | $14,410,597 | +2.3% | 5,500,228 | -36.3% | 5.20% | +10.1% |
| Q1 2023 | $14,083,534 | -5.4% | 8,640,205 | -22.8% | 4.72% | -24.6% |
| Q4 2022 | $14,889,601 | -26.2% | 11,195,189 | -13.4% | 6.26% | -30.9% |
| Q3 2022 | $20,168,000 | +12.4% | 12,928,168 | +11.0% | 9.07% | +8.7% |
| Q2 2022 | $17,937,000 | -11.6% | 11,647,417 | +47.0% | 8.34% | -0.8% |
| Q1 2022 | $20,286,000 | +22.4% | 7,924,056 | +40.1% | 8.41% | +10.6% |
| Q4 2021 | $16,573,000 | – | 5,656,373 | – | 7.60% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 5,641,920 | $10,493,971 | 39.87% |
| Stonepine Capital Management, LLC | 5,915,372 | $11,002,592 | 3.66% |
| MPM BioImpact LLC | 3,987,967 | $7,417,619 | 1.98% |
| SINECERA CAPITAL, LLC | 253,101 | $470,768 | 0.63% |
| Opaleye Management Inc. | 390,000 | $725,400 | 0.24% |
| Alpine Global Management, LLC | 300,000 | $558,000 | 0.14% |
| DELTEC ASSET MANAGEMENT LLC | 315,246 | $586,358 | 0.13% |
| Redmile Group, LLC | 1,046,587 | $1,946,652 | 0.09% |
| GSA CAPITAL PARTNERS LLP | 381,231 | $709 | 0.06% |
| Soleus Capital Management, L.P. | 304,083 | $565,594 | 0.05% |